Return
to Module VII
1. Anonymous. Overview of Dietary Supplements. U.S. Food and Drug Administration. http://vm.cfsan.fda.gov/~dms/ds-oview.html May 1997.
2. Anonymous. FDA Guide to Dietary Supplements. U.S. Food and Drug Administration. http://vm.cfsan.fda.gov/~dms/fdsupp.html September 1998.
3. Anonymous. The Special Nutritionals Adverse Event Monitoring System. U.S. Food and Drug Administration. http://vm.cfsan.fda.gov/~dms/aems.html September 1998.
4. Micromedex Healthcare Series: MICROMEDEX Inc., Englewood, Colorado (Edition expires [11/30/98]).
5. Jorgensen KM, Witting MD. Does Exogenous Melatonin Improve Day Sleep or Night Alertness in Emergency Physicians Working Night Shifts? Annals of Emergency Medicine. 1998; 31(6): 699-704.
6. Anonymous. Chaparral, in Olin BR (ed): The Lawrence Review of Natural Products. Facts and Comparisons, St. Louis, Aug 1993.
7. Gordon DW, Rosenthal G, Hart J, Sirota R, Baker AL. Chaparral and Liver Toxicity. JAMA. 1995; 273:489-490.
8. Anderson IB et al. Pennyroyal Toxicity. Ann Intern Med. 1996;124:726-734.
9. Anonymous. Pennyroyal, in Olin BR (ed): The Lawrence Review of Natural Products. Facts and Comparisons, St. Louis, Jul 1998.
10. Anonymous. St. John’s Wort, in Olin BR (ed): The Lawrence Review of Natural Products. Facts and Comparisons, St. Louis, Nov 1997.
11. Anonymous. FDA Talk Paper. FDA Warns Against Drug Promotion of “Herbal Fen-Phen”. http://www.fda.gov/bbs/topics/ANSWERS/ANS00832.html November 1997. Alternative web site: http://www.fda.gov
12. Anonymous. MayoClinic. Dietary Supplements. Worrisome contaminants found. http://www.mayo.edu/news/5htp/users.htm
13. Anonymous. Valerian, in Olin BR (ed): The Lawrence Review of Natural Products. Facts and Comparisons, St. Louis, Oct 1991.
14. Willey LB, Mady SP, Cobaugh DJ, Wax PM. Valerian overdose: a case report. Veterinary & Human Toxicology. 1995; 37(4): 364-5.
15. Anonymous. Kava-Kava, in Olin BR (ed):
The Lawrence Review of Natural Products. Facts and Comparisons, St. Louis,
May 1987.
References have been included at the end of every discussion for your convenience.